epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Bupap
    butalbital/ acetaminophen
  • remove Effer-K
    potassium bicarbonate
  • remove Panlor SS
    acetaminophen/ caffeine/ dihydrocodeine

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Bupap (butalbital/ acetaminophen) + Panlor SS (acetaminophen/ caffeine/ dihydrocodeine)

Avoid/Use Alternative


acetaminophen + acetaminophen

limit acetaminophen from all sources to standard max acetaminophen doses: combo may incr. acetaminophen levels, risk of hepatotoxicity, other adverse effects (additive effects, duplicate therapy)

butalbital + dihydrocodeine

use alternative or monitor respiratory rate, withdrawal sx; consider decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may decr. dihydrocodeine and active metabolite dihydromorphine levels, efficacy; may incr. risk of profound CNS and respiratory depression, psychomotor impairment (hepatic metabolism induced, may decr. production of active metabolite dihydromorphine; additive effects)

Additional Considerations

Smiley face Smiley face dihydrocodeine in Panlor SS

consider prescribing an opioid overdose reversal agent, especially with concomitant CNS depressant use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information